University Of North Carolina Oncology 101 Manning Dr BLDG 2, Chapel Hill, NC 27514 9199664431 (phone), 9199666735 (fax)
Education:
Medical School University of Washington SOM Graduated: 2004
Languages:
English Spanish
Description:
Dr. Carlson graduated from the University of Washington SOM in 2004. She works in Chapel Hill, NC and specializes in Medical Oncology. Dr. Carlson is affiliated with North Carolina Memorial Hospital.
American Board of Internal Medicine Certification in Internal Medicine American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine) American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Name / Title
Company / Classification
Phones & Addresses
Cheryl Carlson Attorney
Contract Compliance Hub and Leap Highway, Street, and Bridge Construction
747 Market St, Tacoma, WA 98402 2535915825
Cheryl Carlson Attorney
City of Tacoma Urban/Community Development · Legislative Body · General Government · Equipment Rental/Leasing · Administrative Social/Manpower Programs · Tax & License Division · Individual and Family Services, Nsk · Individual/Family Services
747 Market St, Tacoma, WA 98402 2535915200, 2535915012, 2535912035, 2535915564
Cheryl Carlson Attorney
Pioneer Park Pavillion Misc Personal Services
330 S Meridian, Puyallup, WA 98371
Cheryl Carlson
Valley Arts United Theatrical Producers/Services
333 S Meridian, Puyallup, WA 98371 Puyallup, WA 98371
Cheryl A. Carlson Medical Doctor
Carlos A Pellegrini MD Medical Doctor's Office · Surgeons
1959 NE Pacific St, Seattle, WA 98195 2065984477
Us Patents
Recombinant, Modified Adenoviral Vectors For Tumor Specific Gene Expression And Uses Thereof
Dirk S. Steinwaerder - Hamburg, DE Cheryl A. Carlson - Seattle WA Jie Mi - Seattle WA
Assignee:
University of Washington - Seattle WA
International Classification:
C12N 15861
US Classification:
4353201, 435455, 435456, 424 932
Abstract:
This invention provides modified recombinant Ad vectors (e. g. , AdE1- vectors) undergoing defined homologous recombination in order to create predictably rearranged genomic derivatives in a host cell. Genomic rearrangements can be achieved, for example, by incorporating two IR sequences within one vector genome and enabling genomic rearrangement by coinfection with two parental vectors of one type (also referred to herein as a one vector system) or by homologous recombination of overlapping regions in two distinct types of parental vectors (with or without IR sequences) and enabling genomic rearrangement only upon coinfection of the host cell with the two distinct parental vectors (also referred to herein as two vector system).